Compare

    Two terms, side by side

    Pick any two terms to see definitions, context, pitfalls, and sources in parallel.

    Curated comparison tables

    In-depth, attribute-by-attribute tables for the most common MedTech term pairs. Each row is sourced from the linked term pages.

    Manufacturing

    Lot Traceability

    In one line
    Ability to trace materials, processes, and devices forward and backward through the supply chain by lot number.
    Definition
    21 CFR 820.65 requires traceability for devices intended for surgical implant or whose failure could cause significant injury. Lot traceability links UDI-PI to inputs, processes, and finished-goods distribution records. Under the QMSR, traceability follows ISO 13485 clause 7.5.9, with extra requirements for implantable devices including records of components, materials and work environment conditions. Good traceability lets a company scope a recall to specific lots. The EU MDR also requires distributors and health institutions to store UDIs for certain implantable devices.
    Why it matters
    Effective traceability is the difference between scoping a recall to a few lots versus the entire installed base.
    Common pitfalls
    • •Failing to link all unique device identification, production identifiers (UDI-PI) to their corresponding manufacturing records and raw material lots is a common mistake.
    • •Inadequate documentation of each stage of the manufacturing process, from raw materials to final distribution, can severely hamper traceability efforts during an audit or recall.
    • •Lax control over third-party logistics and distribution partners can create gaps in the traceability chain.
    • •Not regularly testing or auditing the traceability system through mock recalls is a critical oversight.
    • •Relying solely on paper-based systems without adequate backups or digital integration can lead to data loss and inefficiencies.
    Open full page
    Select term B to compare.

    Why compare MedTech terms side by side?

    MedTech terminology is full of pairs that look interchangeable but carry very different regulatory, clinical, and commercial consequences. Picking the wrong framework, pathway, or standard early in a project can add months to a submission, invalidate clinical evidence, or trigger an audit finding. Side-by-side comparison is the fastest way to surface those differences before they become costly mistakes.

    Each comparison on this page pulls from the same vendor-neutral, sourced definitions used throughout the MedTech Terms glossary. You see the one-line summary, the formal definition, why it matters in practice, common pitfalls, and the primary sources (FDA guidance, EU MDR/IVDR articles, ISO/IEC standards, MDCG documents, IMDRF principles) that back each entry. That makes the comparison defensible in regulatory strategy memos, design reviews, and submission narratives.

    Common comparison patterns

    How to use this tool

    Pick term A and term B from the dropdowns, or click a preset above. The URL updates with both slugs so you can bookmark or share the exact comparison with a colleague, a notified body reviewer, or your regulatory consultant. Click Open full page on either side for the complete entry, including FAQs, related terms, and the full citation list. If you are not sure which term to start with, browse the Categories view or the A-Z index.

    MedTech Terms is a vendor-neutral community resource sponsored by Blue Goat Cyber. Definitions are written for educational use and are not legal or regulatory advice.